InvestorsHub Logo
Followers 164
Posts 17228
Boards Moderated 0
Alias Born 09/13/2007

Re: None

Monday, 03/12/2018 4:37:23 PM

Monday, March 12, 2018 4:37:23 PM

Post# of 158771
interesting -
read from "OWN THE FLOAT.COM" today :

"PAO Group, PAOG also has the same CEO as Rising Biosciences, Robert Weber. This is another stock that falls into the same pattern of trading as I stated in the above paragraph. I feel this company is way undervalued as well with the major progress they have made in treating a variety of diseases with their unique customized approach, but as per the companies mission, mainly geared to opioid addicted therapies. Additionally, their expansion into several legal states with the new corporate owned centers, has lead to sharp increase in revenues reported by the company. The opioid crisis is a major problem that is happening right now in this country and is growing at an alarming rate. POAG has aligned itself in a sector that is not only much needed for this country in battling the opioid addictions, but can be very lucrative as well for shareholders."